opensafely / antibody-and-antiviral-deployment

While vaccines remain the best strategy to prevent COVID-19, mAbs could potentially benefit certain vulnerable populations before or after exposure to SARS-CoV-2, such as the unvaccinated or recently vaccinated high-risk patients.
MIT License
1 stars 4 forks source link

Update study_definition.py #6

Closed rose-higgins closed 2 years ago

gitpod-io[bot] commented 2 years ago

rose-higgins commented 2 years ago

@acagreen17 just updated the liver disease codelists, as think they were just a typo (were in as CKD codelists)